Cargando…

UMOD and you! Explaining a rare disease diagnosis

The precise molecular genetic diagnosis of a rare inherited disease is nearly always a prolonged odyssey. Fortunately, modern molecular testing strategies are allowing more diagnoses to be made. There are many different rare inherited kidney diseases and both the genetic heterogeneity of these condi...

Descripción completa

Detalles Bibliográficos
Autores principales: Mabillard, Holly, Olinger, Eric, Sayer, John A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9767401/
https://www.ncbi.nlm.nih.gov/pubmed/36569465
http://dx.doi.org/10.1007/s44162-022-00005-4
_version_ 1784853959375060992
author Mabillard, Holly
Olinger, Eric
Sayer, John A.
author_facet Mabillard, Holly
Olinger, Eric
Sayer, John A.
author_sort Mabillard, Holly
collection PubMed
description The precise molecular genetic diagnosis of a rare inherited disease is nearly always a prolonged odyssey. Fortunately, modern molecular testing strategies are allowing more diagnoses to be made. There are many different rare inherited kidney diseases and both the genetic heterogeneity of these conditions and the clinical diversity often leads to confusing nomenclature. Autosomal dominant tubulointerstitial kidney disease (ADTKD) is an example of this. ADTKD, an inherited kidney disease that leads to worsening of kidney function over time, often culminating in end stage kidney disease, accounting for around 2% of this cohort. UMOD is the most common gene implicated in this disorder but there are at least 6 subtypes. At present, there are no specific treatments for ADTKD. Here, we review the current understanding of this condition and provide patient-centred information to allow conceptual understanding of this disease to allow better recognition, diagnosis and management.
format Online
Article
Text
id pubmed-9767401
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-97674012022-12-21 UMOD and you! Explaining a rare disease diagnosis Mabillard, Holly Olinger, Eric Sayer, John A. J Rare Dis (Berlin) Review The precise molecular genetic diagnosis of a rare inherited disease is nearly always a prolonged odyssey. Fortunately, modern molecular testing strategies are allowing more diagnoses to be made. There are many different rare inherited kidney diseases and both the genetic heterogeneity of these conditions and the clinical diversity often leads to confusing nomenclature. Autosomal dominant tubulointerstitial kidney disease (ADTKD) is an example of this. ADTKD, an inherited kidney disease that leads to worsening of kidney function over time, often culminating in end stage kidney disease, accounting for around 2% of this cohort. UMOD is the most common gene implicated in this disorder but there are at least 6 subtypes. At present, there are no specific treatments for ADTKD. Here, we review the current understanding of this condition and provide patient-centred information to allow conceptual understanding of this disease to allow better recognition, diagnosis and management. Springer Berlin Heidelberg 2022-12-07 2022 /pmc/articles/PMC9767401/ /pubmed/36569465 http://dx.doi.org/10.1007/s44162-022-00005-4 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Review
Mabillard, Holly
Olinger, Eric
Sayer, John A.
UMOD and you! Explaining a rare disease diagnosis
title UMOD and you! Explaining a rare disease diagnosis
title_full UMOD and you! Explaining a rare disease diagnosis
title_fullStr UMOD and you! Explaining a rare disease diagnosis
title_full_unstemmed UMOD and you! Explaining a rare disease diagnosis
title_short UMOD and you! Explaining a rare disease diagnosis
title_sort umod and you! explaining a rare disease diagnosis
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9767401/
https://www.ncbi.nlm.nih.gov/pubmed/36569465
http://dx.doi.org/10.1007/s44162-022-00005-4
work_keys_str_mv AT mabillardholly umodandyouexplainingararediseasediagnosis
AT olingereric umodandyouexplainingararediseasediagnosis
AT sayerjohna umodandyouexplainingararediseasediagnosis